Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02941029 · ClinicalTrials.gov registry record
RADTOX: Measuring Radiation Toxicity Using Circulating DNA
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 68
- Enrollment target
NCT02941029 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 68 participants.
The verdict
NCT02941029 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
This research study is being done to develop a new test to identify prostate cancer patients at highest risk of radiotherapy-related complications. This research study would allow monitoring of total tissue damage within 24 hours of radiation exposure in blood samples that could give an initial result within a few days that would help clinicians make treatment decisions. Detection of unusual tissue damage at this early time, well before symptoms occur, could allow doctors to tailor interventions that could include patient therapies that would reduce or prevent the problems that occur due to treatment of their cancer.
Interventions
- OTHER Plasma Blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2016-10 |
| Est. Completion | 2017-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02941029
The ClinicalTrials.gov registry entry for NCT02941029 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasma Blood collection is the first listed.
NCT02941029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02941029 about?
NCT02941029 is a clinical study titled "RADTOX: Measuring Radiation Toxicity Using Circulating DNA". This research study is being done to develop a new test to identify prostate cancer patients at highest risk of radiotherapy-related complications. This research study would allow monitoring of total tissue damage within 24 hours of radiation exposure in blood samples that could give an initial resu...
What is the current status of trial NCT02941029?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2016-10. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02941029?
The interventions under investigation include: Plasma Blood collection (OTHER).
Who is sponsoring clinical trial NCT02941029?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.